Octave’s Post

The recently published clinical utility study in Multiple Sclerosis Journals - Experimental, Translational and Clinical reinforces the impact of the Octave multiple sclerosis disease activity (MSDA) test on clinical decision making and patient management. Join Drs. Gabriel Pardo, MD, FAAN, Jacqueline Nicholas, MD, MPH and Mitzi Joi Williams M.D., FAAN at the Friday May 30 Supporter Showcase as they deep dive into the study and its applications at #CMSC2025. For our full line up of activities, visit https://lnkd.in/gBkkGfwK   #OctaveBioscience #MSCare #MSDAtest #ClinicalResearch #PrecisionMedicine